About EuroClone
EuroClone is a company based in Milan (Italy) founded in 1986. EuroClone offers products and services including Biotechnology Products, Customer Support Services, and Laboratory Equipment. EuroClone operates in a competitive market with competitors including Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
- Headquarter Milan, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website euroclonegroup.it
- Social LinkedIn X Facebook
- Legal Name Euroclone S.P.A.
- Latest Funding Round$68.15K (USD), Grant
Oct 2021
- Investors
Products & Services of EuroClone
EuroClone offers a comprehensive portfolio of products and services, including Biotechnology Products, Customer Support Services, and Laboratory Equipment.
Innovative items for biomedical research and applications
Technical assistance for equipment and products
Equipment for cytogenetics and biomedical analysis
Funding Insights of EuroClone
- Total Rounds 2
- Last Round Grant — $68,147
- First Round $651,680
(Dec 2016)
- Investors Count 1
All 2 funding rounds of EuroClone with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $68,147 | Grant | – | – | |
| Dec 2016 | $651,680 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in EuroClone
EuroClone has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for EuroClone
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of EuroClone
3 dated milestones of EuroClone across 35 years, from founding to its latest funding, stage changes and deals.
- Founded EuroClone is founded.
- Funding First funding round of $652K.
- Funding Latest funding round, Grant, of $68K.
Competitors of EuroClone
EuroClone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Inscripta, Stem Cell Technologies, GenScript and OncoDNA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| oncodna.com | 2012 | Charleroi, Belgium | $44.53M | 37 | Genomic and theranostic services for oncology precision medicine are delivered. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| diagenode.com | 2003 | Seraing, Belgium | $8.45M | 99 | Reagents and kits for epigenetics sequencing solutions are developed. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | – | Proprietary reagents for single-cell genetic analysis are developed. | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders |
Detailed competitors of EuroClone
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EuroClone
The website of EuroClone (euroclonegroup.it) receives about 5.6K visits a month.
- Monthly visits5.6K
▼ 15.9% vs previous month
Websites whose visitors overlap most with EuroClone. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioatlas.com | 100% | – | – | View details | |
| enzynomics.com | 99% | – | #1,023,859 | View details | |
| toolsbiotech.com | 99% | – | #1,993,135 | View details | |
genedirex.com | genedirex.com | 98% | – | #2,561,325 | – |
| pubcompare.ai | 95% | 17.3K | #1,624,771 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for EuroClone
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to EuroClone
10 companies that operate in the same segment as EuroClone (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EuroClone
EuroClone was founded in 1986 and raised its 1st funding round 30 years after it was founded.
EuroClone is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
EuroClone was founded in 1986 in Milan, Italy, as a biotech company focused on the development and manufacturing of instruments, reagents, and kits. Operations span biotechnology for research applications including cell culture, cytogenetics, DNARNA analysis, proteins, and endotoxin detection; medical devices such as surgical instruments; and AgLive for agricultural and veterinary diagnostics. Products are distributed through these sectors to support RD and clinical needs.
EuroClone's top competitors include Abcam, Sino Biological and OncoDNA.
EuroClone offers Biotechnology Products, Customer Support Services, and Laboratory Equipment.
EuroClone has 1 investor. Key investors include European Union.
EuroClone operates through Euroclone S.P.A..